PATENT CLAIM ANALYSIS

Application Number: 16041458
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-06
Patent Classification: ["546", "156000"]

Abstract:
Provision of a stabilized crystal of 6-(3-chloro-2-fluorobenzyl)-1-[(S)-1-hydroxymethyl-2-methylpropyl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (compound A). A crystal of compound A, which shows a particular X-ray powder diffraction pattern of a characteristic diffraction peaks at diffraction angles 2θ(°) as measured by X-ray powder diffractmetry.

Claim (Index 18):
The method according to  claim 17 , wherein the compound is administered at a dosage for inhibiting activity specific for integrases.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 95.0
- Lexical Diversity: 1.54054
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12538694', '11133471', '11767021', '11446128', '12445130']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7834087722996624
- 35 USC 102 Novelty (BERT): 0.5027856643457556
- Combined Prediction Score: 0.7553464615042718
- Mean Citation Score: 229.205502
- Max Citation Score: 263.12384
- Similarity Product: 193.47516461563112

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test